durvalumab
astrazeneca
['durva', 'mesothelioma']
chemotherapy + durvalumab exhibited promising clinical activity in patients with #mesothelioma, with additional analyses providing insights into genomic &amp; immunologic features associated with response. work led by #aacr23 speakers &amp; 
Nature Medicine is a research journal devoted to publishing the latest advances in translational and clinical research for scientists and physicians.